◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › CV

CapsoVision, Inc. (CV) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-16

CapsoVision, Inc. (CV) operates in the Medical Devices industry and is headquartered in Saratoga, United States with about 99 employees. Its market capitalization is roughly $316 million. In the fiscal year ended 2025-12-31, CV reported $14M in revenue and ($25M) in net income.

CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system.

Interactive charts & full statements → Open the CV valuation workbench →

CV Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-31
Total Revenue$14M$12M$10M
Gross Profit$7M$6M$6M
Operating Income (EBIT)($26M)($20M)($11M)
Net Income($25M)($20M)($11M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CV Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-09-302025-06-302025-03-31
Total Revenue$3M$4M$4M$3M$3M
Gross Profit$1M$2M$2M$2M$2M
Operating Income (EBIT)($7M)($8M)($8M)($5M)($5M)
Net Income($7M)($7M)($8M)($5M)($5M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

CV Free Cash Flow History

CV Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-31
Total Assets$18M$17M$22M
Total Liabilities$5M$146M$131M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive CV viewer.

Other Companies in Medical Devices

← CUZAll stocksCVBF →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.